Assay for TET1 Activity and Its Inhibitors Screening with Signal Amplification by Both Nanoparticles and Ru(III) Redox Recycling

Ying Cheng,Jing Tang,Xue Chen,Fang Wang,Zilin Chen
DOI: https://doi.org/10.1016/j.jpba.2021.114228
IF: 3.571
2021-01-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:Ten-eleven translocation protein 1 (TET1) is one member of TET proteins family which plays a key role in dynamic DNA methylation-demethylation process. Herein, a novel biosensor was constructed for TETI detection and its inhibitors screening utilizing restriction digestion of endonuclease enzyme MspI. Half-methylated oligonucleotide (5mC DNA) was used as target and Ru(NH3)(6)(3+) as electrochemical signal probe. After the treatment by TETI and T4 beta-glucosyltransferase (T4 beta-GT), target oligonucleotide would not be recognized and digested. If there was no TETI, the target would be digested and the response of biosensor decreased greatly. The current difference of biosensor with and without the incubation with TETI was therefore dependent on the concentration of TETI. To increase sensitivity of the biosensor, nanostructured film at electrode surface and nanoparticles modified oligonucleotides were employed as signal amplification elements for Ru(NH3)(6)(3+) recycling. Finally, this biosensor showed high performance with a wide linear range of TETI concentration from 3.5-21 ng/mu L and a low detection limit of 0.33 ng/mu L, which is superior to other existing methods. The inhibition effects of Bobcat339 on TETI was successfully proved by our biosensor with an IC50 of 38 mu M. Not only that, but the feasibility of the biosensor for inhibitors screening was evaluated and further confirmed by other compounds including two anticancer drugs and three active ingredients of traditional Chinese medicine. (C) 2021 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?